Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
915.53
840.19
1,006.59
595.17
685.84
655.67
683.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
915.53
840.19
1,006.59
595.17
685.84
655.67
683.79
Raw Material Cost
249.19
205.38
290.03
157.25
176.34
169.81
206.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.79
0.87
5.86
1.47
1.01
1.52
1.15
Selling and Distribution Expenses
581.39
463.83
596.18
373.48
405.56
355.42
436.75
Other Expenses
2.30
1.51
1.32
1.71
1.86
1.47
1.69
Total Expenditure (Excl Depreciation)
855.35
685.14
905.32
549.32
601.48
541.48
660.98
Operating Profit (PBDIT) excl Other Income
60.199999999999996
155
101.30000000000001
45.9
84.39999999999999
114.2
22.799999999999997
Other Income
16.37
12.60
11.75
13.12
14.53
19.12
40.55
Operating Profit (PBDIT)
84.83
175.64
115.81
67.85
101.25
136.78
64.11
Interest
1.79
0.87
5.86
1.47
1.01
1.52
1.15
Exceptional Items
0.40
0.19
-1.85
0.27
0.45
0.15
70.51
Gross Profit (PBDT)
666.34
634.81
716.56
437.92
509.50
485.86
477.61
Depreciation
8.81
8.81
9.15
9.15
5.72
5.72
5.75
Profit Before Tax
74.63
166.15
98.95
57.50
94.97
129.69
127.71
Tax
23.78
30.95
-4.08
-5.26
28.57
19.07
23.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.70
135.05
102.83
62.27
65.91
110.63
85.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.70
135.05
102.83
62.27
65.91
110.63
85.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.15
0.15
-0.25
0.49
0.50
-0.00
17.48
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
50.84
135.20
102.58
62.76
66.40
110.62
103.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,365.54
3,515.39
3,380.41
3,377.36
3,315.13
3,457.74
3,347.13
Earnings per share (EPS)
0.13
0.34
0.26
0.16
0.16
0.28
0.21
Diluted Earnings per share
0.13
0.34
0.26
0.16
0.16
0.28
0.21
Operating Profit Margin (Excl OI)
6.52%
18.36%
9.43%
7.66%
11.81%
17.07%
2.6%
Gross Profit Margin
9.11%
20.82%
10.74%
11.2%
14.68%
20.65%
19.52%
PAT Margin
5.54%
16.07%
10.22%
10.46%
9.61%
16.87%
12.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 33.49% vs 19.23% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -23.49% vs 26.48% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -20.99% vs 44.02% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 80.00% vs -44.44% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Guangdong Marubi Biotechnology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
915.53
0
915.53
Other Operating Income
0.00
0.00
0.00
Total Operating income
915.53
0
915.53
Raw Material Cost
249.19
0
249.19
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.79
0
1.79
Selling and Distribution Expenses
581.39
0
581.39
Other Expenses
2.30
0.00
2.30
Total Expenditure (Excl Depreciation)
855.35
0
855.35
Operating Profit (PBDIT) excl Other Income
60.19
0.00
60.19
Other Income
16.37
0
16.37
Operating Profit (PBDIT)
84.83
0
84.83
Interest
1.79
0
1.79
Exceptional Items
0.40
0
0.40
Gross Profit (PBDT)
666.34
0
666.34
Depreciation
8.81
0
8.81
Profit Before Tax
74.63
0
74.63
Tax
23.78
0
23.78
Provisions and contingencies
0
0
0.00
Profit After Tax
50.70
0
50.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.70
0
50.70
Share in Profit of Associates
0
0
0.00
Minority Interest
0.15
0
0.15
Other related items
0.00
0.00
0.00
Consolidated Net Profit
50.84
0
50.84
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,365.54
0
3,365.54
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
6.52%
0%
0.00
6.52%
Gross Profit Margin
9.11%
0%
0.00
9.11%
PAT Margin
5.54%
0%
0.00
5.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 91.55 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 8.96% vs -16.53% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 33.49% vs 19.23% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.08 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -62.43% vs 31.77% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -23.49% vs 26.48% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.85 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -57.98% vs 56.58% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -20.99% vs 44.02% in Jun 2024
Quarterly - Interest
Interest 0.18 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 100.00% vs -84.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 80.00% vs -44.44% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.52%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
